1. Home
  2. SILO

SILO

Silo Pharma Inc.

Logo Silo Pharma Inc.

Consumer Discretionary

Apparel

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Founded: 2010 Country:
United States
United States
Employees: N/A City: SARASOTA
Market Cap: 6.0M IPO Year: N/A
Target Price: $10.00 AVG Volume (30 days): 134.5K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.20 EPS Growth: N/A
52 Week Low/High: $1.22 - $3.05 Next Earning Date: 01-01-0001
Revenue: $72,102 Revenue Growth: N/A
Revenue Growth (this year): 1.86% Revenue Growth (next year): N/A

Share on Social Networks: